The Precision Peptide Genetic Test reveals your predispositions in peptide genetic pathways, showing how variants in genes like GLP1R rs6923761 and GIPR rs1800437 affect your natural GLP-1 response
At the top dose, 45.3% of participants lost at least 30% of their body weight, and 65.3% reached a BMI below 30
Greater precision tends to produce more predictable pharmacologic effects, while variability can introduce uncertainty in both dosing and outcomes
The initial results of clinical trials have showcased the impressive weight loss benefits of GLP-1 analogues, such as semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide
The guarantee should be understood within the context of the specific conditions outlined in the terms of use rather than as an unconditional money-back promise
For example, they might use 2.4 mg for 12 weeks, then reduce to 1.0 mg for 4 weeks, then return to 2.4 mg